Lifecore Biomedical Reports Q2 2026 Results; Issues Investor Presentation

What Happened

• On August 5, 2026, Lifecore Biomedical, Inc. (LFCR) announced its consolidated financial results for the quarter and six months ended June 30, 2026. The company furnished a press release (Exhibit 99.1) reporting those quarterly results and posted investor presentation materials on its website (Exhibit 99.2) under Regulation FD disclosure. The Form 8-K was signed by CFO Ryan D. Lake.

Key Details

• Filing date: August 5, 2026 (Form 8-K Items 2.02 and 7.01).
• Period covered: Quarter and six months ended June 30, 2026.
• Materials furnished: Press Release (Exhibit 99.1) and Investor Presentation (Exhibit 99.2).
• The 8‑K also includes the Inline XBRL cover page (Exhibit 104).

Why It Matters

• This filing announces the company’s latest quarterly results and makes investor materials available — essential sources for investors to review revenue, earnings and operating performance for Q2 and the year‑to‑date period. The press release and investor presentation contain the detailed financial figures and management commentary investors should consult to assess recent performance and short‑term outlook.